GCM
PAHC icon

Gladius Capital Management’s Phibro Animal Health PAHC Stock Holding History

Gladius Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,725
Closed -$38.8K – 202
2024
Q3 		$38.8K Sell
1,725
-90
-5% -$1.74K ﹤0.01% 165
2024
Q2 		$30.4K Sell
1,815
-1,385
-43% -$22.3K ﹤0.01% 252
2024
Q1 		$41.4K Buy
3,200
+450
+16% +$5.39K 0.01% 201
2023
Q4 		$31.8K Buy
2,750
+708
+35% +$7.99K 0.01% 267
2023
Q3 		$26.1K Buy
2,042
+47
+2% +$666 ﹤0.01% 325
2023
Q2 		$27.3K Sell
1,995
-267
-12% -$3.83K ﹤0.01% 271
2023
Q1 		$34.7K Sell
2,262
-826
-27% -$12.6K ﹤0.01% 259
2022
Q4 		$41.4K Buy
3,088
+634
+26% +$8.5K ﹤0.01% 210
2022
Q3 		$33K Sell
2,454
-1,099
-31% -$19K ﹤0.01% 286
2022
Q2 		$68K Buy
+3,553
New +$67.3K ﹤0.01% 229

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Gladius Capital Management's PAHC Position: Q4 2024 in Review

Gladius Capital Management sold out of Phibro Animal Health (PAHC) in Q4 2024, closing a stake of 1,725 shares — an estimated $38.8K sold.

Gladius Capital Management first reported a position in PAHC in Q2 2022 and held it in 10 quarters. The position peaked at $68K in Q2 2022. 172 funds tracked by Wall St. Rank hold PAHC as of Q4 2024.

  • Gladius Capital Management reported no remaining Phibro Animal Health position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 1,725 Phibro Animal Health shares in Q4 2024, an estimated $38.8K.
  • Gladius Capital Management first reported a position in Phibro Animal Health in Q2 2022 and held it in 10 quarters.
  • Gladius Capital Management's Phibro Animal Health position peaked at $68K in Q2 2022.
  • 172 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.